Hin Sang Group (International) Holding Co. Ltd. (6893) AI Stock Analysis

• Market Cap: HK$251.11M
• Dividend Yield: N/A
• Average Volume (3M): 146.87K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.22
• Revenue Growth: 10.42%
• EPS Growth: 11.14%
• Country: HK
• Employees: 230
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): >-0.01
• Shares Outstanding: 1,091,796,000
• 10 Day Avg. Volume: 47,000
• 30 Day Avg. Volume: 146,866
• PEG Ratio: -0.13
• Price to Book (P/B): 1.46
• Price to Sales (P/S): 2.47
• P/FCF Ratio: -53.15
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 49 Neutral
• Price Target: HK$0.20 ▼(-28.21% Downside)
• Action: Reiterated Date: 11/28/25
• Date: Action: Reiterated 11/28/25

The overall stock score is primarily impacted by the company's weak financial performance, characterized by ongoing losses and high leverage. While technical analysis shows positive momentum, the overbought indicators suggest caution. The negative P/E ratio and lack of dividend yield further weigh on the valuation score.

Positive Factors

Revenue Growth Trend

Sustained ~10.4% revenue growth indicates the company can expand top-line over time, supporting scale economics. Over a 2–6 month horizon, persistent revenue growth provides a base to improve operating leverage and fund restructuring or reinvestment despite current losses.

Healthy Gross Profit Margin

A relatively healthy gross margin gives the business a structural cushion to cover fixed SG&A and absorb cost volatility. If management controls overhead, this margin base supports a credible path to restoring positive operating margins over several quarters.

Moderate Equity Ratio

A moderate equity ratio implies a non-trivial shareholder capital buffer that stabilizes the balance sheet. This structural equity base improves refinancing options and reduces bankruptcy probability versus a virtually all-debt capital structure.

Negative Factors

High Leverage

Debt-to-equity above 2 denotes materially elevated leverage that increases interest burden and refinancing risk. Overcoming this requires sustained cash generation or external capital; high leverage constrains strategic flexibility and raises solvency sensitivity to revenue shocks.

Consistent Net Losses

Persistent net losses and negative ROE erode retained earnings and hinder internal funding of operations or capex. Without profitable operations, the company risks further balance sheet deterioration and must rely on external financing to sustain growth or restructure.

Weak Cash Generation

Significantly negative free cash flow and poor cash conversion mean operations do not fund corporate needs. Structurally weak cash generation forces dependence on debt or equity raises, limits capex and working capital flexibility, and increases default risk under stress.

Hin Sang Group (International) Holding Co. Ltd. Business Overview & Revenue Model

Company Description

Hin Sang Group (International) Holding Co. Ltd., together with its subsidiaries, primarily engages in the manufacture, marketing, and sale of healthcare products primarily targeting at children in Hong Kong and Mainland China. The company operates through four segments: Product Development, Brand Development and Management, Trading of Goods, and Healthcare. The Product Development segment develops and sells personal care products, household products, and health supplements under the Hin Sang, Tai Wo Tong, Cheers Smart, Care Plus, Shuang Long, and King's Antiseptic brand names. The Brand Development and Management segment engages in marketing, selling and distribution, logistics, and delivery services of personal care products under the Pahmi, Enear, Vcnic, Zici, and Sunew brand names; and manages and develops brands for its brand proprietors. The Trading of Goods segment engages in the distribution and sale of skin care products, personal care products, and household products purchased from various authorized dealers, independent traders, manufacturers, parallel importers, and suppliers. The Healthcare segment provides Chinese medical healthcare related services for mothers and children; develops mother and child related health products; and hospital, medical center, and related services. It is also involved in the trading of skin care, personal care, and slimming products; and property holding business. The company sells its products in Hong Kong, as well as sells through a network of distributors in the People's Republic of China and Macau. It also sells its products online. The company was founded in 1996 and is headquartered in Tsim Sha Tsui, Hong Kong. Hin Sang Group (International) Holding Co. Ltd. is a subsidiary of Genwealth Group Holding Company Limited.

How the Company Makes Money

The company generates revenue through multiple streams, including direct sales of its health food products across various retail channels, online sales through e-commerce platforms, and wholesale distribution to other retailers and businesses. Hin Sang Group also capitalizes on strategic partnerships with suppliers and distributors to enhance its market reach and product offerings. Additionally, the company may benefit from brand recognition and customer loyalty in the health and wellness sector, contributing to its overall earnings.

Hin Sang Group (International) Holding Co. Ltd. Financial Statement Overview

Summary

Hin Sang Group faces significant financial challenges, with ongoing losses and high leverage. Despite some revenue growth, profitability and cash flow management remain critical issues. The company needs to focus on improving operational efficiency and reducing debt to enhance financial stability.

Income Statement

Hin Sang Group has shown some revenue growth, but profitability remains a significant concern. The gross profit margin is relatively healthy, but the company has been consistently operating at a net loss, with negative EBIT and EBITDA margins. This indicates challenges in managing operational costs and achieving profitability.

Balance Sheet

The company's balance sheet reveals high leverage, with a debt-to-equity ratio above 2, indicating potential financial risk. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is moderate, suggesting some stability in asset financing.

Cash Flow

Cash flow analysis shows negative free cash flow growth and a low operating cash flow to net income ratio, highlighting cash management issues. The free cash flow to net income ratio is significantly negative, indicating that the company is not generating sufficient cash from its operations to cover its losses.

Breakdown	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement
Total Revenue	91.89M	92.62M	81.46M	120.55M	119.44M
Gross Profit	60.28M	57.41M	38.84M	69.08M	68.79M
EBITDA	-16.57M	-3.58M	-17.05M	21.82M	-4.35M
Net Income	-49.36M	-36.70M	-49.49M	-11.91M	-31.95M
Balance Sheet
Total Assets	555.73M	587.85M	618.28M	693.77M	711.82M
Cash, Cash Equivalents and Short-Term Investments	19.87M	19.35M	12.44M	17.58M	18.05M
Total Debt	344.41M	321.10M	318.42M	320.91M	345.50M
Total Liabilities	399.61M	378.52M	378.37M	391.97M	392.24M
Stockholders Equity	155.28M	208.84M	239.38M	301.59M	318.28M
Cash Flow
Free Cash Flow	-4.27M	5.62M	-3.79M	23.65M	-53.16M
Operating Cash Flow	638.00K	6.29M	402.00K	23.99M	10.65M
Investing Cash Flow	-4.73M	-585.00K	-2.09M	15.20M	-63.72M
Financing Cash Flow	6.27M	-4.87M	-93.00K	-41.67M	55.34M

Hin Sang Group (International) Holding Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.28
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6893, the sentiment is Neutral. The current price of 0.28 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.27, and above the 200-day MA of 0.22, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.74 is Neutral, neither overbought nor oversold. The STOCH value of 39.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:6893.

Hin Sang Group (International) Holding Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1455	70 Outperform	HK$305.58M	16.57	5.40%	6.41%	-34.28%	-45.72%
1962	69 Neutral	HK$292.48M	5.20	3.77%	10.32%	-6.67%	-29.55%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
3332	62 Neutral	HK$696.65M	6.41	4.03%	―	-0.92%	-71.88%
2023	58 Neutral	HK$383.60M	2.21	10.92%	―	11.10%	-4.38%
6893	49 Neutral	HK$251.11M	-5.88	-23.55%	―	10.42%	11.14%